A precipitation-based chromatography alternative, a novel viral vector isolation tech, and a glycosylation prediction system are among the projects awarded funding in the latest round of grants issued ...

These microbes produce metabolites that might be used to treat bacterial infections, cancer, type 2 diabetes, and much more.

With several surfactants to choose from, the biopharma industry is still working to identify the most effective, environmentally friendly alternatives to the surfactant Triton X-100 (TX-100). The EU ...

Genmab says choosing to insource cell-line development helped them to improve the antibody titers they were achieving.